Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Clinical presentation and treatment of orthopaedic implant‐associated infection

W Zimmerli - Journal of internal medicine, 2014 - Wiley Online Library
Orthopaedic implants are highly susceptible to infection. The aims of treatment of infection
associated with internal fixation devices are fracture consolidation and prevention of chronic …

Hip and knee section, treatment, debridement and retention of implant: proceedings of international consensus on orthopedic infections

JN Argenson, M Arndt, G Babis… - The Journal of …, 2019 - arthroplastyjournal.org
One or more of the authors of this paper have disclosed potential or pertinent conflicts of
interest, which may include receipt of payment, either direct or indirect, institutional support …

[HTML][HTML] Orthopaedic device-related infection: current and future interventions for improved prevention and treatment

TF Moriarty, R Kuehl, T Coenye… - EFORT open …, 2016 - eor.bioscientifica.com
Orthopaedic and trauma device-related infection (ODRI) remains one of the major
complications in modern trauma and orthopaedic surgery. Despite best practice in medical …

Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: a review of cohort studies

STJ Tsang, J Ting, A Simpson… - The bone & joint …, 2017 - boneandjoint.org.uk
Aims The aims of the study were to review and analyse the reported series of debridement,
antibiotics and implant retention (DAIR) in the management of infected total hip …

Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections

W Zimmerli, P Sendi - Antimicrobial Agents and Chemotherapy, 2019 - Am Soc Microbiol
Rifampin has been used as an agent in combination therapy in orthopedic device-related
infections (ODRI) for almost three decades. The aim of this review is to provide data …

Rifamycins, alone and in combination

DM Rothstein - Cold Spring Harbor perspectives …, 2016 - perspectivesinmedicine.cshlp.org
Rifamycins inhibit RNA polymerase of most bacterial genera. Rifampicin remains part of
combination therapy for treating tuberculosis (TB), and for treating Gram-positive prosthetic …

[HTML][HTML] Treatment of acute periprosthetic infections with prosthesis retention: review of current concepts

JWP Kuiper, RT Willink, DJF Moojen… - World journal of …, 2014 - ncbi.nlm.nih.gov
Periprosthetic joint infection (PJI) is a devastating complication after total joint arthroplasty,
occurring in approximately 1%-2% of all cases. With growing populations and increasing …

[HTML][HTML] Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections

JS Davis, S van Hal, SYC Tong - Seminars in respiratory and …, 2015 - thieme-connect.com
Outcomes from methicillin-resistant Staphylococcus aureus (MRSA) infections are relatively
poor, at least in part due to the limitations of vancomycin (the current standard treatment for …

Outcome of debridement, antibiotics, and implant retention for staphylococcal hip and knee prosthetic joint infections, focused on rifampicin use: a systematic review …

H Scheper, LM Gerritsen, BG Pijls… - Open forum …, 2021 - academic.oup.com
The treatment of staphylococcal prosthetic joint infection (PJI) with debridement, antibiotics,
and retention of the implant (DAIR) often results in failure. An important evidence gap …